Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe
Spotlight

Texas Proposes 2027 Workers’ Comp Research Agenda

Stakeholders can submit feedback on the research agenda through September 28th.
Read More →
August 31, 2026
Spotlight

Florida Finalizes Physician Dispensing Rule Change

The change aligns workers’ comp rules with a February 2026 court ruling on pharmacy choice.
Read More →
August 24, 2026
Spotlight

Alaska Proposes Significant Pharmacy Reimbursement Changes

Impacted drugs include physician-dispensed and repackaged drugs, topicals, compounds, and OTC medications.
Read More →
August 17, 2026

SAMHSA Recommends States Plan for Legal Implications of FDA-Approved Psychedelics

States are encouraged to plan now for the implications of potential psychedelic therapies, including Medicaid coverage obligations.
Read More →
August 31, 2026

New York Proposes Fee Schedule Updates

The proposed changes will have a 45-day public comment period for stakeholders to provide feedback.
Read More →
August 31, 2026

Minnesota Publishes Workers’ Compensation System Report

The report overviewed data from 2004 to the present, focused on claims, benefits, costs, vocational rehab, disputes, and dispute resolution.
Read More →
August 31, 2026

California Backtracks on Naturopathic Doctors Treating Injured Workers

Negative feedback from employers, insurers, and medical organizations resulted in the removal of this proposed clause.
Read More →
August 31, 2026

California Reports Increase in Independent Bill Reviews

Approximately 3,675 IBR applications were filed in the first half of 2026, much higher than the 2,541 during the same period in 2025.
Read More →
August 24, 2026

California Bill Could Allow Naturopathic Doctors to Treat Injured Workers

According to the American Medical Association, the most highly educated naturopaths get only a fraction of the training that physicians receive.
Read More →
August 24, 2026
1 2 3 … 61

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.
Read More

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th, with written comments accepted until October 5th.
Read More

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2026!

Visit Healthe at Booth #415 to chat and pick up a copy of RxInformer magazine, or sit in on our panel discussion.
Read More

State Activity Surrounding Physician Dispensing

Florida, Pennsylvania, and Michigan have recently made waves regarding physician dispensing.
Read More

Emerging Therapies: Phase 3 Data for LSD-Based Drug in Major Depression

Patients taking DT120 for major depressive disorder experienced significant drops in depression symptoms.
Read More

Healthesystems at WCI 2026

Visit Healthe at Booth #921, and don’t forget to check out two educational sessions featuring Healthe leaders!
Read More
1 2 3 … 52
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle